Conventional drug development process
- 01Lab Drug Synthesis
- 02Drug Characterization & Analysis
- 03Simple in-vitro Cell Based Drug Evaluation
- 04Animal Model Based Drug Evaluation
- 05Mass Production
Innovative drug development process
Improved accuracy in evaluating new drug candidates
Reduced cost and duration of new drug development
-
-
01Microfluidics-Standardized Drug Synthesis
Standardization of drug synthesis through controlled flow patterns of microfluidic technology
Minimal batch-to-batch variability through a single continuous synthesis process
Multiple precursors Incorporatable through single-step synthesis
-
- 02Drug Characterization & Analysis
-
-
03Human Organ Model Chip Based Drug Evaluation
Accurate drug evaluation through human organ-level function simulation
Overcoming the cross-species difference from animal models
Accurate drug development for rare diseases through stem or patient cells
-
- 04Minimum Animal Model Based Drug Evaluation
-
-
05Integrated Microfluidics Based Mass Production
Integrated microfluidic reactor system
Mass production of standardized drug synthesis through reproduction of controlled flow patterns
Reproducing drug performance in clinical translation (bench to bedside)
